LogicBio
Cambridge, US · Founded 2014 · Delaware corporation · 2 known investors
LogicBio is a biotechnology company focused on research and development of treatments for rare diseases, investigating new targets, modalities, and technologies for patients and their families worldwide.
Founders & leadership
LL
Leszek LisowskiExecutive Officer, Director
EC
Erez ChimovitsDirector
MA
Mark A. KayDirector
AB
Adi BarzelExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$29.2MraisedJul 2017 · 9 investors · BiotechnologyRule 506(b)
▶$29.2MraisedJul 2017 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MARC RUBENSTEINExecutive Officer
- TOMER KARIVDirector
- MARK A. KAYDirector
- LEON CHENDirector
- EREZ CHIMOVITSDirector
- SOFIA IOANNIDOUDirector
- DANIEL O'CONNELLDirector
- FREDERIC CHEREAUExecutive Officer, Director
- Offering amount
- $44.9M
- Amount sold
- $29.2M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedJan 2016 · 1 investors · Other Health CareRule 506(b)
▶$4MraisedJan 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Leszek LisowskiExecutive Officer, Director
- Erez ChimovitsDirector
- Mark A. KayDirector
- Adi BarzelExecutive Officer, Director
- Offering amount
- $5.4M
- Amount sold
- $4M
- Minimum investment
- $1
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.